The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Persistent Negative Symptoms in Schizophrenia: An Overview
Open accessAbstract
Persistent negative symptoms represent an alternative approach for assessing negative symptoms in the context of clinical trials. Persistent negative symptoms are designed to capture those symptoms that lead to functional impairment but are currently understudied and for which there are no currently available effective treatments. Persistent negative symptoms differ from the 2 most commonly used approaches: primary, enduring negative symptoms or deficit symptoms and negative symptoms broadly defined to include negative symptoms, regardless of their etiology or duration. In contrast to deficit symptoms, persistent negative symptoms may include secondary negative symptoms. However, in contrast to negative symptoms broadly defined, the secondary negative symptoms included in the assessment of persistent negative symptoms only include those that have failed to respond to usual treatments for secondary negative symptoms. In consequence, the presence of persistent negative symptoms identifies a patient population with clinically relevant symptomatology, which is larger than the one with the deficit syndrome but less heterogeneous than that captured through the use of a nonrestrictive definition of negative symptoms. This may facilitate the selection of subjects for inclusion into research and efforts to develop new pharmacological treatments and enhance our understanding of a relevant clinical problem. Ultimately, the investigation of the different entities characterized by negative symptoms, such as persistent negative symptoms, and the enhanced understanding of their biological and clinical characteristics may help to unravel the psychopathological and biological heterogeneity of schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Dementia Praecox or the Group of Schizophrenias
(1951) · Journal of the American Medical Association · doi:10.1001/jama.1951.02920270079043 · Cited by 4,407
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,264
Dementia Praecox and Paraphrenia.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1058_8 · Cited by 2,901
Negative Symptoms in Schizophrenia: Definition and Reliability
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070020005 · Cited by 2,247
Negative v Positive Schizophrenia: Definition and Validation
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070025006 · Cited by 2,012
Molecular pathology of schizophrenia: more than one disease process?
Crow, T. J. (1980) · BMJ · doi:10.1136/bmj.280.6207.66 · Cited by 1,856
Deficit and nondeficit forms of schizophrenia: the concept
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.5.578 · Cited by 1,332
The NIMH-MATRICS Consensus Statement on Negative Symptoms
Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., & Marder, S. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj053 · Cited by 1,311
A depression rating scale for schizophrenics
Addington, D., Addington, J., & Schissel, B. (1990) · Schizophrenia Research · doi:10.1016/0920-9964(90)90005-r · Cited by 1,269
Risperidone in the treatment of schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.825 · Cited by 1,193
Milev, P., Ho, B.-C., Arndt, S., & Andreasen, N. C. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.495 · Cited by 920
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.457 · Cited by 891
The Two-syndrome Concept: Origins and Current Status
Crow, T. J. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.471 · Cited by 839
The schedule for the deficit syndrome: An instrument for research in schizophrenia
Kirkpatrick, B., Buchanan, R. W., McKenny, P. D., Alphs, L. D., & Carpenter, W. T. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90153-4 · Cited by 808
Self-citationA standardized psychiatric assessment scale for rating chronic psychotic patients
Krawiecka, M., Goldberg, D., & Vaughan, M. (1977) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1977.tb00174.x · Cited by 677
A Separate Disease Within the Syndrome of Schizophrenia
Kirkpatrick, B., Buchanan, R. W., Ross, D. E., & Carpenter, W. T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.2.165 · Cited by 651
Self-citationPart III. Speculations on the Processes That Underlie Schizophrenic Symptoms and Signs
Strauss, J. S., Carpenter, W. T., & Bartko, J. J. (1974) · Schizophrenia Bulletin · doi:10.1093/schbul/1.11.61 · Cited by 574
Treatment of Negative Symptoms
Carpenter, W. T., Heinrichs, D. W., & Alphs, L. D. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.440 · Cited by 499
Efficacy of High-Dose Glycine in the Treatment of Enduring Negative Symptoms of Schizophrenia
Heresco-Levy, U., Javitt, D. C., Ermilov, M., Mordel, C., Silipo, G., & Lichtenstein, M. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.1.29 · Cited by 487
Structural Abnormalities in the Frontal System in Schizophrenia: A Magnetic Resonance Imaging Study
Andreasen, N. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020042006 · Cited by 487
Negative Symptoms and Cognitive Deficits: What Is the Nature of Their Relationship?
Harvey, P. D., Koren, D., Reichenberg, A., & Bowie, C. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj011 · Cited by 462
Buchanan, R. W. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi020 · Cited by 438
Self-citationGoff, D. C., Tsai, G., Levitt, J., Amico, E., Manoach, D., Schoenfeld, D. A., Hayden, D. L., McCarley, R., & Coyle, J. T. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.1.21 · Cited by 436
Rating scales in mental health
(2013) · Choice Reviews Online · doi:10.5860/choice.50-5349 · Cited by 318
Buchanan, R. W., Breier, A., Kirkpatrick, B., Ball, P., & Carpenter, W. T. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.751 · Cited by 264
Self-citationIntroductory Textbook of Psychiatry
(2020) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373758 · Cited by 249
Domains of psychopathology: an approach to the reduction of heterogeneity in schizophrenia.
Buchanan, R. W., & Carpenter, W. T. (1994) · PubMed · Cited by 210
Self-citationPeralta, V., & Cuesta, M. J. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00003-1 · Cited by 195
Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia
Loo, H., Poirier-Littre, M.-F., Theron, M., Rein, W., & Fleurot, O. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.170.1.18 · Cited by 195
Improvement of Schizophrenic Patients With Primary Negative Symptoms Treated With Amisulpride
Danion, J.-M., Rein, W., Fleurot, O., & the Amisulpride Study Group (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.610 · Cited by 185
Social Adjustment and Cognitive Performance of High-Risk Children
Sohlberg, S. C., & Yaniv, S. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.1.61 · Cited by 176
Negative and Deficit Symptoms in Schizophrenia Do Respond to Neuroleptics
Goldberg, S. C. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.453 · Cited by 174
Strong Inference, Theory Testing, and the Neuroanatomy of Schizophrenia
Carpenter, W. T. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820220081009 · Cited by 164
The negative symptom assessment: a new instrument to assess negative symptoms of schizophrenia.
Alphs, L. D., Summerfelt, A. T., Lann, H. D., & Muller, R. J. (1989) · PubMed · Cited by 143
The Effect of Neuroleptics and Other Psychotropic Drugs on Negative Symptoms in Schizophrenia
Meltzer, H. Y., Sommers, A., & Luchins, D. J. (1986) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198612000-00002 · Cited by 143
Improvement of some schizophrenic deficit symptoms with low doses of amisulpride
Martinot, M. P., Lecrubier, Y., Martinot, J., & Aubin, F. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.1.130 · Cited by 142
Kurtz, M. M. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi004 · Cited by 124
Greenwood, K., Landau, S., & Wykes, T. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi035 · Cited by 122
d-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia
Evins, A. E., Amico, E. T., Posever, T. A., Toker, R., & GOFF, D. C. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00220-1 · Cited by 120
Kelley, M. E., van Kammen, D. P., & Allen, D. N. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.3.406 · Cited by 119
Clozapine's effect on negative symptoms in treatment-refractory schizophrenics
Miller, D. D., Perry, P. J., Cadoret, R. J., & Andreasen, N. C. (1994) · Comprehensive Psychiatry · doi:10.1016/0010-440x(94)90164-3 · Cited by 110
Speller, J. C., Barnes, T. R. E., Curson, D. A., Pantelis, C., & Alberts, J. (1997) · The British Journal of Psychiatry · doi:10.1192/bjp.171.6.564 · Cited by 103
The deficit state in first-episode schizophrenia
Mayerhoff, D. I., Loebel, A. D., Alvir, J., Szymanski, S., Geisler, S. H., Borenstein, M., & Lieberman, J. A. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1417 · Cited by 100
Effects of -cycloserine on negative symptoms in schizophrenia
Duncan, E., Szilagyi, S., Schwartz, M. P., Bugarski‐Kirola, D., Kunzova, A., Negi, S., Stephanides, M., Efferen, T. R., Angrist, B., Peselow, E. D., et al. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.03.013 · Cited by 94
Contemporary Issues in the Treatment of Schizophrenia
Shriqui, C. L., & Nasrallah, H. A. (1995) · Medical Entomology and Zoology · Cited by 87
The deficit syndrome in schizophrenia: implications for the treatment of negative symptoms
Arango, C., Buchanan, R. W., Kirkpatrick, B. W., & Carpenter, W. T. (2004) · European Psychiatry · doi:10.1016/j.eurpsy.2003.10.004 · Cited by 86
Self-citationFamily characteristics of deficit and nondeficit schizophrenia in the Roscommon family study
Kirkpatrick, B. W., Ross, D. E., Walsh, D., Karkowski, L. M., & Kendler, K. S. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00164-4 · Cited by 84
LAUGHREN, T. P., & Levin, R. L. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi039 · Cited by 79
Differential Efficacy of Olanzapine for Deficit and Nondeficit Negative Symptoms in Schizophrenia
Kopelowicz, A. J., Zárate, R., Tripodis, K., González, V., & Mintz, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.987 · Cited by 77
Tandon, R., DeQuardo, J. R., Taylor, S. F., McGrath, M., Jibson, M. D., Eiser, A. S., & Goldman, M. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00163-2 · Cited by 75
Olanzapine Treatment of Residual Positive and Negative Symptoms
Buchanan, R. W., Ball, M. P., Weiner, E., Kirkpatrick, B. W., Gold, J. M., McMahon, R. P., & Carpenter, W. T. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.124 · Cited by 59
Self-citationSibling Correlation of Deficit Syndrome in the Irish Study of High-Density Schizophrenia Families
Ross, D. E., Kirkpatrick, B., Karkowski, L. M., Straub, R. E., MacLean, C. J., O’Neill, F. A., Compton, A. D., Murphy, B. M., Walsh, D., & Kendler, K. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1071 · Cited by 57
An Industry Perspective on the NIMH Consensus Statement on Negative Symptoms
Alphs, L. D. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj056 · Cited by 50
Clinical constructs and therapeutic discovery
Carpenter, W. T. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.003 · Cited by 45
Ronald Bottlender, A., Wegner, U., Wittmann, J., Strauß, A., & Möller, H. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014182 · Cited by 37
Deficit syndrome in older schizophrenic patients
Harris, M. J., Jeste, D. V., Krull, A. J., Montague, J. R., & Heaton, R. K. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90094-6 · Cited by 34
Factor structure of the negative symptom assessment
Axelrod, B. N., GOLDMAN, R. S., Woodard, J. L., & Alphs, L. D. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90086-8 · Cited by 31
The deficit syndrome of the psychotic illness: A clinical and nosological study
Peralta, V., & Cuesta, M. J. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0464-7 · Cited by 27
The new pharmacotherapy of schizophrenia
Breier, A. F. (1996) · American Psychiatric Press eBooks · Cited by 19
Kulhara, P., & Avasthi, A. (2003) · European Psychiatry · doi:10.1016/s0924-9338(03)00062-2 · Cited by 18
Negative Symptom Assessment of Chronic Schizophrenia Patients
Raskin, A., Pelchat, R. J., Sood, R., Alphs, L. D., & Levine, J. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.3.627 · Cited by 17
McAdams, L. A., Harris, M. J., Heaton, S. C., et al. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00066-2 · Cited by 11
Cited by
Garland, E. L., Fredrickson, B., Kring, A. M., Johnson, D. P., Meyer, P. S., & Penn, D. L. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.03.002 · Cited by 1,035
“Additionally, individuals with negative symptoms have significant impairments in motivation, treatment adherence, social functioning and long-term outcome relative to others with schizophrenia (Bowie, Reichenberg, Patterson, Heaton, & Harvey, 2006b; Buchanan, 2007).”
Correll, C. U., & Schooler, N. R. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s225643 · Cited by 911
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Negative symptoms of schizophrenia: new developments and unanswered research questions
Galderisi, S., Mucci, A., Buchanan, R. W., & Arango, C. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30050-6 · Cited by 555
Self-citationPrefrontal Cortex and Social Cognition in Mouse and Man
Bicks, L. K., Koike, H., Akbarian, S., & Morishita, H. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.01805 · Cited by 500
Metadata
- Authors
- Buchanan, R. W.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-03-15
- Volume
- 33
- Issue
- 4
- Pages
- 1013-1022
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2171111401
- Cited by
- 443
- References
- 67
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.